???pagination.result.count???
Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine. , Scholz EP., Naunyn Schmiedebergs Arch Pharmacol. November 1, 2003; 368 (5): 404-14.
Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. , Parisi S., J Cell Biol. October 27, 2003; 163 (2): 303-14.
Inhibition of cardiac sodium currents by toluene exposure. , Cruz SL., Br J Pharmacol. October 1, 2003; 140 (4): 653-60.
Expression of ErbB receptors in ES cell-derived cardiomyocytes. , Suk Kim H., Biochem Biophys Res Commun. September 12, 2003; 309 (1): 241-6.
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. , Dell'Era P., Circ Res. September 5, 2003; 93 (5): 414-20.
GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation. , Peterkin T., EMBO J. August 15, 2003; 22 (16): 4260-73.
Human beta(3)-adrenoreceptors couple to KvLQT1/ MinK potassium channels in Xenopus oocytes via protein kinase C phosphorylation of the KvLQT1 protein. , Kathöfer S., Naunyn Schmiedebergs Arch Pharmacol. August 1, 2003; 368 (2): 119-26.
Induction of cardiomyocytes by GATA4 in Xenopus ectodermal explants. , Latinkić BV., Development. August 1, 2003; 130 (16): 3865-76.
Csm, a cardiac-specific isoform of the RNA helicase Mov10l1, is regulated by Nkx2.5 in embryonic heart. , Ueyama T., J Biol Chem. August 1, 2003; 278 (31): 28750-7.
Beating is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes. , Iijima Y., FASEB J. July 1, 2003; 17 (10): 1361-3.
KCNQ1 channels sense small changes in cell volume. , Grunnet M., J Physiol. June 1, 2003; 549 (Pt 2): 419-27.
The complete mouse nebulin gene sequence and the identification of cardiac nebulin. , Kazmierski ST., J Mol Biol. May 9, 2003; 328 (4): 835-46.
ATP-sensitive potassium channel traffic regulation by adenosine and protein kinase C. , Hu K., Neuron. May 8, 2003; 38 (3): 417-32.
Molecular determinants of cAMP-mediated regulation of the Na+-Ca2+ exchanger expressed in human cell lines. , He LP., J Physiol. May 1, 2003; 548 (Pt 3): 677-89.
Hypoxia-induced switches of myosin heavy chain iso-gene expression in rat heart. , Razeghi P., Biochem Biophys Res Commun. April 18, 2003; 303 (4): 1024-7.
Dynorphin B is an agonist of nuclear opioid receptors coupling nuclear protein kinase C activation to the transcription of cardiogenic genes in GTR1 embryonic stem cells. , Ventura C., Circ Res. April 4, 2003; 92 (6): 623-9.
Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells. , Hidaka K., FASEB J. April 1, 2003; 17 (6): 740-2.
The sodium-activated potassium channel is encoded by a member of the Slo gene family. , Yuan A., Neuron. March 6, 2003; 37 (5): 765-73.
Nkx2.5 homeoprotein regulates expression of gap junction protein connexin 43 and sarcomere organization in postnatal cardiomyocytes. , Kasahara H., J Mol Cell Cardiol. March 1, 2003; 35 (3): 243-56.
Regulation of KCNE1-dependent K(+) current by the serum and glucocorticoid-inducible kinase ( SGK) isoforms. , Embark HM., Pflugers Arch. February 1, 2003; 445 (5): 601-6.
Polycystin-2 interacts with troponin I, an angiogenesis inhibitor. , Li Q ., Biochemistry. January 21, 2003; 42 (2): 450-7.
Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels: mode of action. , Kushida S., Eur J Pharmacol. December 13, 2002; 457 (1): 19-27.
Interaction with GM130 during HERG ion channel trafficking. Disruption by type 2 congenital long QT syndrome mutations. Human Ether-à- go-go-Related Gene. , Roti EC., J Biol Chem. December 6, 2002; 277 (49): 47779-85.
PCBs alter gene expression of nuclear transcription factors and other heart-specific genes in cultures of primary cardiomyocytes: possible implications for cardiotoxicity. , Borlak J., Xenobiotica. December 1, 2002; 32 (12): 1173-83.
The human heart and rat brain IIA Na+ channels interact with different molecular regions of the beta1 subunit. , Zimmer T., J Gen Physiol. December 1, 2002; 120 (6): 887-95.
Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. , Shin CH., Cell. September 20, 2002; 110 (6): 725-35.
Hop is an unusual homeobox gene that modulates cardiac development. , Chen F., Cell. September 20, 2002; 110 (6): 713-23.
Human cardiac inwardly-rectifying K+ channel Kir(2.1b) is inhibited by direct protein kinase C-dependent regulation in human isolated cardiomyocytes and in an expression system. , Karle CA., Circulation. September 17, 2002; 106 (12): 1493-9.
The induction of an ATP-sensitive K(+) current in cardiac myocytes of air- and water-breathing vertebrates. , Paajanen V., Pflugers Arch. September 1, 2002; 444 (6): 760-70.
Spironolactone increases integrin beta3 gene expression in kidney and heart muscle cells. , Chun TY., Mol Cell Endocrinol. August 30, 2002; 194 (1-2): 175-82.
Cardiomyogenic differentiation in cardiac myxoma expressing lineage-specific transcription factors. , Kodama H., Am J Pathol. August 1, 2002; 161 (2): 381-9.
HIV type 1 glycoprotein 120 inhibits cardiac myocyte contraction. , Chen F., AIDS Res Hum Retroviruses. July 20, 2002; 18 (11): 777-84.
Csx/ Nkx2-5 is required for homeostasis and survival of cardiac myocytes in the adult heart. , Toko H., J Biol Chem. July 5, 2002; 277 (27): 24735-43.
The Polycomb-group gene Rae28 sustains Nkx2.5/ Csx expression and is essential for cardiac morphogenesis. , Shirai M., J Clin Invest. July 1, 2002; 110 (2): 177-84.
Differential regulation of the cardiac sodium calcium exchanger promoter in adult and neonatal cardiomyocytes by Nkx2.5 and serum response factor. , Müller JG., J Mol Cell Cardiol. July 1, 2002; 34 (7): 807-21.
[Evaluation of pro-arrhythmic risk of drugs due to QT interval prolongation by the HERG expression system]. , Chachin M., Nihon Yakurigaku Zasshi. June 1, 2002; 119 (6): 345-51.
Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. , Preisig-Müller R., Proc Natl Acad Sci U S A. May 28, 2002; 99 (11): 7774-9.
Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation. , Wei L., Development. April 1, 2002; 129 (7): 1705-14.
Molecular characterization of regenerated cardiomyocytes derived from adult mesenchymal stem cells. , Fukuda K., Congenit Anom (Kyoto). March 1, 2002; 42 (1): 1-9.
Inhibition of cardiac potassium currents by pentobarbital. , Bachmann A., Naunyn Schmiedebergs Arch Pharmacol. January 1, 2002; 365 (1): 29-37.
Regulation of heart development and function through combinatorial interactions of transcription factors. , Nemer G., Ann Med. December 1, 2001; 33 (9): 604-10.
Embryonic expression of an Nkx2-5/Cre gene using ROSA26 reporter mice. , Moses KA., Genesis. December 1, 2001; 31 (4): 176-80.
DCPIB is a novel selective blocker of I(Cl,swell) and prevents swelling-induced shortening of guinea-pig atrial action potential duration. , Decher N., Br J Pharmacol. December 1, 2001; 134 (7): 1467-79.
SAP97 interacts with Kv1.5 in heterologous expression systems. , Murata M., Am J Physiol Heart Circ Physiol. December 1, 2001; 281 (6): H2575-84.
BMP signaling regulates Nkx2-5 activity during cardiomyogenesis. , Jamali M., FEBS Lett. November 30, 2001; 509 (1): 126-30.
The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation. , Yamagishi H., Dev Biol. November 15, 2001; 239 (2): 190-203.
Nkx2-5 activity is essential for cardiomyogenesis. , Jamali M., J Biol Chem. November 9, 2001; 276 (45): 42252-8.
Characterization of two Bunodosoma granulifera toxins active on cardiac sodium channels. , Goudet C., Br J Pharmacol. November 1, 2001; 134 (6): 1195-206.
Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes. , Bachmann A., Naunyn Schmiedebergs Arch Pharmacol. November 1, 2001; 364 (5): 472-8.
Amiloride derivatives are potent blockers of KATP channels. , Bollensdorff C., Naunyn Schmiedebergs Arch Pharmacol. October 1, 2001; 364 (4): 351-8.